skip to main content
Idioma:
Refinado por: assunto: Adolescent remover assunto: Male remover Hematology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma
A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma

Morschhauser, Franck ; Feugier, Pierre ; Flinn, Ian W. ; Gasiorowski, Robin ; Greil, Richard ; Illés, Árpád ; Johnson, Nathalie A. ; Larouche, Jean-François ; Lugtenburg, Pieternella J. ; Patti, Caterina ; Salles, Gilles A. ; Trněný, Marek ; de Vos, Sven ; Mir, Farheen ; Samineni, Divya ; Kim, Su Y. ; Jiang, Yanwen ; Punnoose, Elizabeth ; Sinha, Arijit ; Clark, Emma ; Spielewoy, Nathalie ; Humphrey, Kathryn ; Bazeos, Alexandra ; Zelenetz, Andrew D.

Blood, 2021-02, Vol.137 (5), p.600-609 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study
Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study

Choquet, Sylvain ; Leblond, Veronique ; Herbrecht, Raoul ; Socié, Gérard ; Stoppa, Anne-Marie ; Vandenberghe, Peter ; Fischer, Alain ; Morschhauser, Franck ; Salles, Gilles ; Feremans, Walter ; Vilmer, Etienne ; Peraldi, Marie-Noelle ; Lang, Philippe ; Lebranchu, Yvon ; Oksenhendler, Eric ; Garnier, Jeanne Luce ; Lamy, Thierry ; Jaccard, Arnaud ; Ferrant, Augustin ; Offner, Fritz ; Hermine, Olivier ; Moreau, Anne ; Fafi-Kremer, Samira ; Morand, Patrice ; Chatenoud, Lucienne ; Berriot-Varoqueaux, Nathalie ; Bergougnoux, Loïc ; Milpied, Noel

Blood, 2006-04, Vol.107 (8), p.3053-3057 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
3
The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma
The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma

Savage, Kerry J. ; Monti, Stefano ; Kutok, Jeffery L. ; Cattoretti, Giorgio ; Neuberg, Donna ; de Leval, Laurence ; Kurtin, Paul ; Cin, Paola Dal ; Ladd, Christine ; Feuerhake, Friedrich ; Aguiar, Ricardo C.T. ; Li, Sigui ; Salles, Gilles ; Berger, Francoise ; Jing, Wen ; Pinkus, Geraldine S. ; Habermann, Thomas ; Dalla-Favera, Riccardo ; Harris, Nancy Lee ; Aster, Jon C. ; Golub, Todd R. ; Shipp, Margaret A.

Blood, 2003-12, Vol.102 (12), p.3871-3879 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
4
Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study
Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study

Bourhis, Jean-Henri ; Bouko, Yasmina ; Koscielny, Serge ; Bakkus, Marleen ; Greinix, Hildegard ; Derigs, Gunter ; Salles, Gilles ; Feremans, Walter ; Apperley, Jane ; Samson, Diana ; Bjorkstrand, Bo ; Niederwieser, Dietger ; Gahrton, Gosta ; Pico, Jose-Luis ; Goldschmidt, Hartmut ; European Group for Blood Marrow Transplantation (EBMT)

Haematologica (Roma), 2007-08, Vol.92 (8), p.1083-1090 [Periódico revisado por pares]

Pavia: Haematologica

Texto completo disponível

Citações Citado por
5
Prognostic value of miR-16 expression in childhood acute lymphoblastic leukemia relationships to normal and malignant lymphocyte proliferation
Prognostic value of miR-16 expression in childhood acute lymphoblastic leukemia relationships to normal and malignant lymphocyte proliferation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic value of miR-16 expression in childhood acute lymphoblastic leukemia relationships to normal and malignant lymphocyte proliferation

Kaddar, T ; Chien, W.W ; Bertrand, Y ; Pages, M.P ; Rouault, J.P ; Salles, G ; Ffrench, M ; Magaud, J.P

Leukemia research, 2009-09, Vol.33 (9), p.1217-1223 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.